PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health
  • NCI (T32CA009686, P30CA051008, R21CA258153, F31CA247417)

This publication has 75 references indexed in Scilit: